ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9849
0.07%
Brent Oil
83.015
-0.13%
Bitcoin
64,085.50
0.14%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Intra Cellular Therapies Inc (ITCI)

  7. Intra Cellular Therapies Inc (ITCI) Noticias

ITCI Intra Cellular Therapies Inc

69.80
-0.54 (-0.77%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Intra Cellular Therapies Inc ITCI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.54 -0.77% 69.80 17:29:53
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
71.07 68.48 71.35 68.80 70.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202407:00GLOBEIntra-Cellular Therapies to Host First Quarter 2024..
24/4/202415:01GLOBEIntra-Cellular Therapies Announces Closing of $575 Million..
17/4/202419:46GLOBEIntra-Cellular Therapies Prices Public Offering of Common..
16/4/202415:06GLOBEIntra-Cellular Therapies Announces Proposed Public Offering..
16/4/202406:00GLOBEIntra-Cellular Therapies Announces Positive Phase 3 Topline..
19/3/202407:30GLOBEIntra-Cellular Therapies Announces Executive Appointments..
11/3/202415:52EDGAR2Form 144 - Report of proposed sale of securities
11/3/202415:38EDGAR2Form 144 - Report of proposed sale of securities
11/3/202415:30EDGAR2Form 144 - Report of proposed sale of securities
08/3/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:44EDGAR2Form 144 - Report of proposed sale of securities
07/3/202415:27EDGAR2Form 144 - Report of proposed sale of securities
07/3/202415:19EDGAR2Form 144 - Report of proposed sale of securities
07/3/202415:17EDGAR2Form 144 - Report of proposed sale of securities
06/3/202407:00GLOBEIntra-Cellular Therapies to Participate in Three Upcoming..
05/3/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202418:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202407:00GLOBEIntra-Cellular Therapies to Present at the 44th Annual TD..
26/2/202415:59EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
26/2/202415:55EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:46EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:33EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:22EDGAR2Form 144 - Report of proposed sale of securities
22/2/202406:42EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202406:39EDGAR2Form 8-K - Current report
22/2/202406:30GLOBEIntra-Cellular Therapies Reports Fourth Quarter And..
08/2/202407:00GLOBEIntra-Cellular Therapies to Host Fourth Quarter and Full..
05/2/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:47EDGAR2Form 144 - Report of proposed sale of securities
02/2/202415:41EDGAR2Form 144 - Report of proposed sale of securities
02/2/202415:39EDGAR2Form 144 - Report of proposed sale of securities
02/2/202415:13EDGAR2Form 144 - Report of proposed sale of securities
18/1/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202416:08EDGAR2Form 144 - Report of proposed sale of securities
04/1/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:38EDGAR2Form 144 - Report of proposed sale of securities
02/1/202407:00GLOBEIntra-Cellular Therapies to Present at the 42nd Annual J.P...
15/12/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ITCI
Intra Cellular Therapies
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados